Click Here to return To Results

 

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy Neurol 72:396-401,392, Stuve,O.,et al, 2009 See this aricle in Pubmed Article Abstract This is the first long-term follow-up of patients who discontinued natalizumab. We did not observe a clinical, radiographic, or immunologic rebound phenomenon after discontinuation of natalizumab therapy.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction complications disability,neurological monoclonal antibodies multiple sclerosis multiple sclerosis,disease activity multiple sclerosis,relapsing multiple sclerosis,treatment of natalizumab natalizumab,discontinuation prognosis safety treatment of neurologic disorder

Click Here to return To Results